Medtronic
MDT
99.94
-0.67
-0.67%
Medtronic
US · MDT
#176 by market cap
Listed 1970
99.94
-0.67
-0.67%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $120Market Newswire · 2026/11/10
-
Leerink Partners Maintains Medtronic(MDT.US) With Buy Rating, Announces Target Price $117Market Newswire · 2026/11/19
-
Rating change
William Blair Maintains Medtronic(MDT.US) With Buy RatingMarket Newswire · 2026/9/11
-
Rating change
J.P. Morgan Maintains Medtronic(MDT.US) With Hold RatingMarket Newswire · 2026/10/16
-
Company notice
Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.SEC · 2026/7/10
-
Rating change
TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110Market Newswire · 2026/9/30
-
Rating change
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110Market Newswire · 2026/10/30
-
Company notice
Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Blomquist Denise L.SEC · 2026/9/17
-
Company notice
Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.SEC · 2026/6/9
-
Company notice
Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Walter Matthew R.SEC · 2026/5/29
-
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $120Market Newswire · 2026/11/16
-
Rating change
BTIG Maintains Medtronic(MDT.US) With Buy Rating, Cuts Target Price to $99Market Newswire · 2026/10/12
-
Rating change
Needham Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $114Market Newswire · 2026/9/17
-
Piper Sandler Upgrades Medtronic(MDT.US) to Buy Rating, Raises Target Price to $120Market Newswire · 2026/11/17
-
Rating change
Citi Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $110Market Newswire · 2026/10/5
-
Rating change
Medtronic shares rose as Morgan Stanley initiated coverage with an "Overweight" rating, citing confidence in the value of the company's platform-based business model.Zhitong Finance · 2026/10/21
-
Company notice
Medtronic | 4: Statement of changes in beneficial ownership of securities-Officer Blomquist Denise L.SEC · 2026/6/9
-
BTIG Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $109Market Newswire · 2026/11/19
-
Rating change
Barclays Downgrades Medtronic(MDT.US) to Hold Rating, Cuts Target Price to $95Market Newswire · 2026/10/8
-
Rating change
RBC Capital Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $118Market Newswire · 2026/10/3
-
Form 144 | Medtronic(MDT.US) Officer Proposes to Sell 4.75 Million in Common StocksMarket Newswire · 2026/10/15
-
Rating change
Wells Fargo Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $104Market Newswire · 2026/9/10
-
Medtronic(MDT.US) Officer Sells US$4.75 Million in Common StockMarket Newswire · 2026/10/17
-
Rating change
UBS Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $110Market Newswire · 2026/9/3
-
Rating change
J.P. Morgan Maintains Medtronic(MDT.US) With Hold Rating, Raises Target Price to $96Market Newswire · 2026/9/4
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.
Medtronic discussion 0 comments